Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:BC_Partners
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:foundedIn |
1969
|
| gptkbp:founder |
gptkb:Dimitris_Katsikostas
|
| gptkbp:headquartersLocation |
gptkb:Athens,_Greece
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pharmathen
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:manufacturingFacilities |
gptkb:Greece
gptkb:India |
| gptkbp:notableFor |
injectable drug delivery systems
sustained release technologies |
| gptkbp:numberOfEmployees |
over 1,000
|
| gptkbp:operatesIn |
global markets
|
| gptkbp:products |
active pharmaceutical ingredients
pharmaceutical formulations |
| gptkbp:regulatoryApprovals |
gptkb:FDA
gptkb:EMA |
| gptkbp:specializesIn |
contract development and manufacturing
research and development of generic pharmaceuticals |
| gptkbp:website |
https://www.pharmathen.com/
|
| gptkbp:bfsParent |
gptkb:BC_Partners
|
| gptkbp:bfsLayer |
7
|